Emerging Biotech Ikonisys Inc. Announces Appointment of Former CEO of Schering AG Advisor to its Board Of Directors NEW HAVEN, Conn., April 15/PRNewswire/ -- Ikonisys, Inc., announced today the appointment of former Schering, AG CEO Dr. Giuseppe Vita as an advisor to its board of directors. Dr. Vita will assist the biotechnology company in developing a business strategy for its technology platform in the field of cell-based diagnostics. Dr. Vita, who is chairman of Schering's supervisory board, has been a member of the global pharmaceutical company's executive board since 1987 and served for more than 20 years as managing director of the Schering subsidiary in Italy. He was Schering's chairman of the executive board from 1989 to 2001. "Dr. Vita is a highly respected industrialist with strategic vision and extensive knowledge of the global pharmaceutical industry and medical diagnostics," said Dr. Petros Tsipouras, CEO of New Haven, Conn.-based Ikonisys, a biotechnology company at the forefront of cell-based diagnostics. "He will be able to provide an enormous amount of insight into the applications we're developing for the detection of Down syndrome, cancer and other diseases." Ikonisys has developed a novel technology platform that identifies and analyzes rare cells with applications in the prenatal detection of genetic disorders and the diagnosis and disease management of cancer and other disorders at a lower cost and less invasively than current diagnostic methods. An important component of the Ikonisys technology platform is the Ikoniscope(TM) microscope, a high-speed, fully automated digital microscope. "Ikonisys is really at the cutting edge of molecular diagnostics," Dr. Vita said. "They are blazing a trail that converges molecular and cellular biology, microscopy, image analysis, and information technology that is really quite unique." As chairman of Schering, Dr. Vita has been actively engaged in advisory groups focused on Germany's position in the international scientific and business arena. He has been honored in Italy and Germany for his contributions toward a better understanding between these two nations and for his support of European integration. Ikonisys, Inc. is a privately held company developing technology in the field of cell-based diagnostics. It is currently developing applications of the technology in the areas of pre-natal diagnosis of chromosomal abnormalities and cancer detection and monitoring. Contact: Angel Streeter of The TransMedia Group, 561-750-9800, ext. 21. AStreeter@transmediagroup.com